MedTrace Logo

Early Detection and Prediction of Chemotherapy Induced Cardiac Toxicity in Breast Cancer Patients

NCT00806507 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 45

Last updated 2012-07-23

No results posted yet for this study

Summary

The goal of this clinical research study is to learn whether different ways of viewing echocardiogram pictures along with blood tests can help to see heart-related side effects of chemotherapy and trastuzumab earlier than the usual tests.

Conditions

Interventions

PROCEDURE

Echocardiograms

Additional views performed in 5-10 minutes of regularly scheduled echocardiograms.

PROCEDURE

Blood Test

Measuring of hormones and metabolic proteins (such as sugars and acids).

Sponsors & Collaborators

  • Massachusetts General Hospital

    collaborator OTHER

  • M.D. Anderson Cancer Center

    lead OTHER

Principal Investigators

  • Jose Banchs, MD · M.D. Anderson Cancer Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-11-30
Primary Completion
2011-08-31
Completion
2011-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00806507 on ClinicalTrials.gov